Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 110Carcinoma, Non-Small-Cell Lung 63Lung Neoplasms 27Hodgkin Disease 14Lymphoma 10Neoplasm Metastasis 9Triple Negative Breast Neoplasms 8Neoplasms 8Recurrence 7Prostatic Neoplasms 7Small Cell Lung Carcinoma 5Sarcoma 5Rhabdomyosarcoma 5Lymphoma, Large B-Cell, Diffuse 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Breast Neoplasms, Male 4Brain Neoplasms 4Adenocarcinoma of Lung 4Ovarian Neoplasms 3NSCLC 3Mesothelioma, Malignant 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Esophageal Squamous Cell Carcinoma 3

Interventions

Docetaxel 5Gemcitabine 3Vinorelbine 2Erlotinib Hydrochloride 2Carboplatin 2surufatinib 1pemigatinib 1nimotuzumab 1lorlatinib 1Pemetrexed 1Paclitaxel 1Gene Expression Profiling 1Cisplatin 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Advanced Non-Small Cell Lung Cancer × Vinorelbine × Clear all
NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 2 Unknown
60 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00345059 2016-01-14

DISTAL-2

National Cancer Institute, Naples

Phase 3 Terminated
84 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡